Redpoint Investment Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Redpoint Investment Management's IDXX Position: Q3 2022 in Review
Redpoint Investment Management reduced its Idexx Laboratories (IDXX) stake by 19% in Q3 2022, selling an estimated $169K and leaving 1,967 shares worth $641K. The position accounts for 0.09% of the portfolio, ranked #269.
Redpoint Investment Management first reported a position in IDXX in Q4 2017 and has held it in 20 quarters since. The position peaked at $1.86M in Q2 2020. 924 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.
- Redpoint Investment Management held 1,967 shares of Idexx Laboratories worth $641K as of Q3 2022.
- Redpoint Investment Management sold 461 Idexx Laboratories shares in Q3 2022, an estimated $169K.
- Idexx Laboratories made up 0.09% of Redpoint Investment Management's portfolio in Q3 2022, its #269 holding.
- Redpoint Investment Management first reported a position in Idexx Laboratories in Q4 2017 and has held it in 20 quarters since.
- Redpoint Investment Management's Idexx Laboratories position peaked at $1.86M in Q2 2020.
- 924 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.
Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.